Cantel Medical (Little Falls, New Jersey) reported changes at its Crosstex International subsidiary. Richard Orofino, president and a former owner of Crosstex, retired after over 50 years with Crosstex, including 3 years following Cantel's acquisition of the company. Gary Steinberg and Mitchell Steinberg, also former owners of Crosstex who previously were executive VPs of Crosstex, have been promoted and will now lead the company. Gary Steinberg has been appointed CEO of Crosstex; Mitchell Steinberg has been named president. Cantel Medical makes infection prevention and control products in the healthcare market.
CDX Holdings (Irving, Texas) said that George Poste, DVM, PhD, was named non-executive vice chairman and chief scientific advisor of CDX Holdings and non-executive chairman of CMDx. Poste has been a director of Caris Dx, and now CDX Holdings, since November of 2006. He also acts as senior technical advisor to Caris, Ltd., which owns a controlling stake in CDX Holdings. CDX Holdings is a newly-formed holding company that is the parent company of Caris Diagnostics (Caris Dx) and Caris Molecular Diagnostics (CMDx).
IRIS International (Chatsworth, California) said that Edward Voboril has been elected to the company's board, expanding the board to eight members. Voboril is currently chairman of the board of Analogic. Voboril retired this year as chairman of Greatbatch. IRIS makes automated in vitro diagnostics.
Mike Ritchey has been national practice leader for RiechesBaird (Irvine, California), with responsibility for developing the company's branding and marketing strategies. Ritchey previously was senior VP of corporate marketing and communications at ev3. RiechesBaird is a brand creation and development firm.